P-610 Growth inhibition of NSCLC xenografts by erlotinib is independent of HER1/2 overexpression and can reliably be monitored by serum tumor markers
- 1 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S246
- https://doi.org/10.1016/s0169-5002(03)92577-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: